Phase 3 Development of Resmetirom: A Selective Thyroid Receptor- Beta Agonist for the Treatment of NASH

Time: 3:00 pm
day: Day Two

Details:

  • Examining the mechanism of action of thyroid receptor beta in the NASH liver
  • Exploring Phase 3 development program for non-cirrhotic NASH
  • Exploring Phase 3 development program for NASH – cirrhosis

Speakers: